Verifying…
Home / Drug A–Z / Ivysolone Ophthalmic Suspension

Ivysolone Ophthalmic Suspension

NAFDAC Reg. No. 04-4067 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Ivysolone Ophthalmic Suspension
NAFDAC number
04-4067
Active ingredient
Prednisolone Acetate
Strength
1%
Form
Suspension/Drops
Pack size
1 x 5 mL (in LDPE bottle)
Manufacturer
Not listed
Applicant (holder)
Dortemag Ventures Limited
Approved
3 Aug 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
2 Aug 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Ivysolone Ophthalmic Suspension is on the NAFDAC register with an active registration (04-4067). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Ivysolone Ophthalmic Suspension

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

PRED FORTE ® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

How to take it and how often
  • Shake well before using
  • Instill one to two drops into the conjunctival sac two to four times daily
  • During the initial 24 to 48 hours, the dosing frequency may be increased if necessary
  • Care should be taken not to discontinue therapy prematurely
  • If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS )
Children
  • The safety and effectiveness
  • Pediatric patients have been established
  • Pediatric patients is supported by evidence from adequate and well-controlled studies of prednisolone acetate ophthalmic suspension
  • Adults with additional data
  • Pediatric patients
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it
  • Information for P atients Advise patients that if eye inflammation or pain persists longer than 48 hours or becomes aggravated, they should consult a physician
  • Advise patients that to prevent eye injury or contamination, care should be taken to avoid touching the bottle tip to eyelids or to any other surface
  • The use of this bottle by more than one person may spread infection
  • Keep bottle tightly closed when not in use
  • Keep out of the reach of children
  • Advise patients that PRED FORTE ® suspension contains benzalkonium chloride, which may be absorbed by soft contact lenses. …
Talk to a doctor first if

PRED FORTE ® suspension is contraindicated in acute untreated purulent ocular infections, in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. …

Warnings

Prolonged use of corticosteroids may result in posterior subcapsular cataract formation and may increase intraocular pressure in susceptible individuals, resulting in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Prolonged use may also suppress the host immune response and thus increase the hazard of secondary ocular infections. If this product is used for 10 days or longer, intraocular pressure should be routinely monitored even though it may be difficult in children and uncooperative patients. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be checked frequently. …

Possible side effects

The following adverse reactions have been identified during use of PRED FORTE ® . Because reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse reactions include elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing. The development of secondary ocular infection (bacterial, fungal, and viral) has occurred. …

Pregnancy and breastfeeding

Pregnancy Prednisolone has been shown to be teratogenic in mice when given in doses 1-10 times the human dose. Dexamethasone, hydrocortisone, and prednisolone were ocularly applied to both eyes of pregnant mice five times per day on days 10 through 13 of gestation. A significant increase in the incidence of cleft palate was observed in the fetuses of the treated mice. There are no adequate well-controlled studies in pregnant women. …

If you take too much

Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-02-02.

Label for prednisolone acetate, the active ingredient registered with NAFDAC.

Check your pack of Ivysolone Ophthalmic Suspension

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Ivysolone Ophthalmic Suspension

What is in Ivysolone Ophthalmic Suspension?

Ivysolone Ophthalmic Suspension contains Prednisolone Acetate (1%), as suspension/drops, according to its NAFDAC registration record.

Is Ivysolone Ophthalmic Suspension registered with NAFDAC?

Yes. Ivysolone Ophthalmic Suspension is listed on the NAFDAC register under registration number 04-4067, and its registration is active as of 28 October 2026.

Has Ivysolone Ophthalmic Suspension been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Ivysolone Ophthalmic Suspension in our automatically synced alert list.

How can I check that my pack of Ivysolone Ophthalmic Suspension is genuine?

Run a free authenticity scan with the NAFDAC number 04-4067, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Ivysolone Ophthalmic Suspension?

Follow your prescription or the leaflet in your pack. The official label says: Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS ).…

What is Ivysolone Ophthalmic Suspension used for?

PRED FORTE ® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. (Summarised from the official U.S. FDA label for prednisolone acetate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Ivysolone Ophthalmic Suspension? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.